Abl silencing inhibits CAS-mediated process and constriction in resistance arteries

Yana Anfinogenova1, Ruping Wang, Qing-fen Li

  • 1Center for Cardiovascular Sciences, Albany Medical College, Albany, NY 12208, USA.

Insights

Abl tyrosine kinase regulates arterial constriction by mediating Crk-associated substrate phosphorylation and actin assembly. Abl deficiency reduces CAS phosphorylation and actin polymerization, impacting arterial smooth muscle function without affecting myosin activation.

Area of Science:

  • Vascular Biology
  • Molecular Cell Biology
  • Biochemistry

Background:

  • Crk-associated substrate (CAS) is involved in actin dynamics and arterial constriction.
  • Phenylephrine (PE) stimulation increases CAS tyrosine phosphorylation and its association with CrkII in rat mesenteric arteries.
  • Abl tyrosine kinase catalyzes CAS phosphorylation in vitro.

Purpose of the Study:

  • To investigate the role of Abl tyrosine kinase in arterial constriction and associated signaling pathways.
  • To determine if Abl mediates CAS phosphorylation and actin assembly in response to contractile stimulation.
  • To elucidate Abl's specific role in smooth muscle contraction regulation.

Main Methods:

  • Silencing of Abl tyrosine kinase using short hairpin RNA (shRNA) delivered via chemical loading and liposomes in rat mesenteric arteries.
  • Assessment of CAS tyrosine phosphorylation and its association with CrkII.
  • Analysis of multiprotein complex assembly (CrkII, N-WASP, Arp2/3) and F/G-actin ratios as indicators of actin polymerization.
  • Measurement of arterial constriction and myosin regulatory light chain phosphorylation (MRLCP).

Main Results:

  • Abl silencing significantly diminished PE-induced increases in CAS tyrosine phosphorylation.
  • Abl deficiency attenuated the assembly of the CrkII, N-WASP, and Arp2/3 complex upon contractile stimulation.
  • Abl-deficient arteries showed reduced actin assembly (F/G-actin ratios) and constriction compared to controls.
  • Myosin regulatory light chain phosphorylation (MRLCP) was not affected by Abl silencing during contractile activation.

Conclusions:

  • Abl tyrosine kinase plays a critical role in mediating CAS phosphorylation, multiprotein complex assembly, and actin assembly in resistance arteries.
  • Abl is essential for contractile stimulation-induced arterial constriction.
  • Abl's function in arterial vessels is specific to regulating actin dynamics and does not involve myosin activation pathways.

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...